Cyclacel Pharmaceuticals (NASDAQ:BGMS – Get Free Report) announced its earnings results on Friday. The company reported ($0.04) earnings per share (EPS) for the quarter, Zacks reports. Cyclacel Pharmaceuticals Stock Performance Shares of Cyclacel Pharmaceuticals stock traded down $0.05 during midday trading on Friday, reaching $1.00. 14,800 shares of the company’s stock traded hands, compared to […]

Eupraxia Pharmaceuticals (NASDAQ:EPRX – Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($0.23) earnings per share for the quarter, missing the consensus estimate of ($0.22) by ($0.01), Zacks reports. Eupraxia Pharmaceuticals Price Performance Shares of NASDAQ EPRX opened at $7.55 on Thursday. The stock has a market capitalization of $456.25 […]

Phio Pharmaceuticals (NASDAQ:PHIO – Get Free Report) announced its earnings results on Thursday. The company reported ($0.34) earnings per share (EPS) for the quarter, FiscalAI reports. Phio Pharmaceuticals Price Performance Phio Pharmaceuticals stock traded down $0.07 during trading hours on Friday, hitting $1.07. 323,552 shares of the stock traded hands, compared to its average volume […]

WELL Health Technologies (TSE:WELL – Get Free Report) posted its earnings results on Thursday. The company reported C$0.06 earnings per share (EPS) for the quarter, FiscalAI reports. WELL Health Technologies had a negative return on equity of 0.87% and a negative net margin of 0.53%.The firm had revenue of C$368.26 million during the quarter. Here […]